GB-7624
/ Generate Biomedicines
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
April 11, 2025
Study to Investigate the Safety, Tolerability, and Pharmacokinetics of GB-7624 in Healthy Adult Participants
(clinicaltrials.gov)
- P1 | N=40 | Recruiting | Sponsor: Generate Biomedicines
New P1 trial • Atopic Dermatitis • Dermatitis • Dermatology • Immunology
1 to 1
Of
1
Go to page
1